Blocking CC chemokine receptor (CCR) 1 and CCR5 during herpes simplex virus type 2 infection in vivo impairs host defence and perturbs the cytokine response

Scandinavian Journal of Immunology

Volumn 59, Issue 3, 2004, Pages 321-333

  Sorensen L N ^a   Paludan, S R ^a  

^a AARHUS UNIVERSITY   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

CHEMOKINE RECEPTOR CCR1; CHEMOKINE RECEPTOR CCR5; CYTOKINE; RANTES;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIVIRAL ACTIVITY; ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOKINE RELEASE; FEMALE; HERPES; HERPES SIMPLEX VIRUS 2; HOST RESISTANCE; IMMUNE RESPONSE; IN VIVO STUDY; LEUKOCYTE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN FUNCTION; VIRUS STRAIN; VIRUS TITRATION;

ANIMALS; BIOLOGICAL ASSAY; BRAIN; CYTOKINES; CYTOTOXICITY TESTS, IMMUNOLOGIC; FEMALE; HERPES SIMPLEX; HERPESVIRUS 2, HUMAN; LEUKOCYTE COUNT; LEUKOCYTES; LIVER; MICE; MICE, INBRED BALB C; MICE, INBRED C57BL; NITRIC OXIDE; RANTES; RECEPTORS, CCR5; RECEPTORS, CHEMOKINE; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA; SPLEEN;

EID: 1842452728     PISSN: 03009475     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.0300-9475.2004.01399.x     Document Type: Article

References (60)

1. Luster AD. Chemokines - chemotactic cytokines that mediate inflammation. N Engl J Med 1998;338:436-45.
2. Melchjorsen J, Sørensen LN, Paludan SR. Expression and function of chemokines during viral infections: from molecular mechanisms to in vivo function. J Leukoc Biol 2003;74:331-43.
3. Baggiolini M. Chemokines in pathology and medicine. J Intern Med 2001;250:91-104.
4. Baggiolini M, Dewald B, Moser B. Human chemokines: an update. Annu Rev Immunol 1997;15:675-705.
5. Sallusto F, Lenig D, Mackay CR, Lanzavecchia A. Flexible programs of chemokine receptor expression on human polarized T helper 1 and 2 lymphocytes. J Exp Med 1998;187:875-83.
6. Kaufmann A, Salentin R, Gemsa D, Sprenger H. Increase of CCR1 and CCR5 expression and enhanced functional response to MIP-1α during differentiation of human monocytes to macrophages. J Leukoc Biol 2001;69:248-52.
7. International Union of Immunological Societies/World Health Organization Subcommittee on Chemokine Nomenclature. Chemokine/chemokine receptor nomenclature. J Leukoc Biol 2001;70:465-6.
8. Yoshimura T, Matsushima K, Tanaka S et al. Purification of a human monocyte-derived neutrophil chemotactic factor that has peptide sequence similarity to other host defense cytokines. Proc Natl Acad Sci USA 1987;84:9233-7.
9. Taub DD, Turcovski-Corrales SM, Key ML, Longo DL, Murphy WJ. Chemokines and T lymphocyte activation. I. β chemokines costimulate human T lymphocyte activation in vitro. J Immunol 1996;156:2095-103.
10. Locati M, Deuschle U, Massardi ML et al. Analysis of the gene expression profile activated by the CC chemokine ligand 5/RANTES and by lipopolysaccharide in human monocytes. J Immunol 2002;168:3557-62.
11. Fischer FR, Luo Y, Luo M, Santambrogio L, Dorf ME. RANTES-induced chemokine cascade in dendritic cells. J Immunol 2001;167:1637-43.
12. Gao JL, Wynn TA, Chang Y et al. Impaired host defense, hematopoiesis, granulomatous inflammation and type 1-type 2 cytokine balance in mice lacking CC chemokine receptor 1. J Exp Med 1997;185:1959-68.
13. Nagasawa T, Hirota S, Tachibana K et al. Defects of B-cell lymphopoiesis and bone-marrow myelopoiesis in mice lacking the CXC chemokine PBSF/SDF-1. Nature 1996;382:635-8.
14. Balashov KE, Rottman JB, Weiner HL, Hancock WW. CCR5(+) and CXCR3(+) T cells are increased in multiple sclerosis and their ligands MIP-1α and IP-10 are expressed in demyelinating brain lesions. Proc Natl Acad Sci USA 1999;96:6873-8.
15. Gerard C, Rollins BJ. Chemokines and disease. Nat Immunol 2001;2:108-15.
16. Dorner BG, Scheffold A, Rolph MS et al. MIP-1α, MIP-1β, RANTES and ATAC/lymphotactin function together with IFN-γ as type 1 cytokines. Proc Natl Acad Sci USA 2002;99:6181-6.
17. Siveke JT, Hamann A. T helper 1 and T helper 2 cells respond differentially to chemokines. J Immunol 1998;160:550-4.
18. Schrum S, Probst P, Fleischer B, Zipfel PF. Synthesis of the CC-chemokines MIP-1α, MIP-1β, and RANTES is associated with a type 1 immune response. J Immunol 1996;157:3598-604.
19. Cook DN, Beck MA, Coffman TM et al. Requirement of MIP-1α for an inflammatory response to viral infection. Science 1995;269:1583-5.
20. Domachowske JB, Bonville CA, Gao JL, Murphy PM, Easton AJ, Rosenberg HF. The chemokine macrophage-inflammatory protein-1 α and its receptor CCR1 control pulmonary inflammation and antiviral host defense in paramyxovirus infection. J Immunol 2000;165:2677-82.
21. Woitas RP, Ahlenstiel G, Iwan A et al. Frequency of the HIV-protective CC chemokine receptor 5-Delta32/Delta32 genotype is increased in hepatitis C. Gastroenterology 2002;122:1721-8.
22. Dawson TC, Beck MA, Kuziel WA, Henderson F, Maeda N. Contrasting effects of CCR5 and CCR2 deficiency in the pulmonary inflammatory response to influenza A virus. Am J Pathol 2000;156:1951-9.
23. Glass WG, Liu MT, Kuziel WA, Lane TE. Reduced macrophage infiltration and demyelination in mice lacking the chemokine receptor CCR5 following infection with a neurotropic coronavirus. Virology 2001;288:8-17.
24. Paludan SR, Melchjorsen J, Malmgaard L, Mogensen SC. Expression of genes for cytokines and cytokine-related functions in leukocytes infected with Herpes simplex virus: comparison between resistant and susceptible mouse strains. Eur Cytokine Netw 2002;13:306-16.
25. Paludan SR, Ellermann-Eriksen S, Kruys V, Mogensen SC. Expression of TNF-α by herpes simplex virus-infected macrophages is regulated by a dual mechanism: transcriptional regulation by NF-κB and activating transcription factor 2/Jun and translational regulation through the AU-rich region of the 3′ untranslated region. J Immunol 2001;167:2202-8.
26. Paludan SR. Requirements for the induction of interleukin-6 by herpes simplex virus-infected leukocytes. J Virol 2001;75:8008-15.
27. Melchjorsen J, Pedersen FS, Mogensen SC, Paludan SR. Herpes simplex virus selectively induces expression of the CC chemokine RANTES/CCL5 in macrophages through a mechanism dependent on PKR and ICP0. J Virol 2002;76:2780-8.
28. Kakimi K, Guidotti LG, Koezuka Y, Chisari FV. Natural killer T cell activation inhibits hepatitis B virus replication in vivo. J Exp Med 2000;192:921-30.
29. Proudfoot AE, Power CA, Hoogewerf AJ et al. Extension of recombinant human RANTES by the retention of the initiating methionine produces a potent antagonist. J Biol Chem 1996;271: 2599-603.
30. Elsner J, Petering H, Hochstetter R et al. The CC chemokine antagonist Met-RANTES inhibits eosinophil effector functions through the chemokine receptors CCR1 and CCR3. Eur J Immunol 1997;27:2892-8.
31. Reiss CS, Komatsu T. Does nitric oxide play a critical tole in viral infections? J Virol 1998;72:4547-51.
32. Adler H, Beland JL, Del Pan NC et al. Supptession of hetpes simplex virus type 1 (HSV-1)-induced pneumonia in mice by inhibition of inducible nitric oxide synthase (iNOS, NOS2). J Exp Med 1997;185:1533-40.
33. Chen BP, Kuziel WA, Lane TE. Lack of CCR2 results in increased mottality and impaired leukocyte activation and trafficking following infection of the central nervous system with a neurotropic coronavirus. J Immunol 2001;167:4585-92.
34. Salazar-Mather TP, Hamilton TA, Biron CA. A chemokine-to-cytokine-to- chemokine cascade critical in antiviral defense. J Clin Invest 2000;105:985-93.
35. Tumpey TM, Cheng H, Cook DN, Smithies O, Oakes JE, Lausch RN. Absence of macrophage inflammatory protein-1α prevents the development of blinding herpes stromal keratitis. J Virol 1998;72:3705-10.
36. Mogensen SC. Macrophages and age-dependent resistance to hepatitis induced by herpes simplex virus type 2 in mice. Infect Immun 1978;19:46-50.
37. Lopez C. Genetics of natural resistance to herpesvirus infections in mice. Nature 1975;258:152-3.
38. Kintner RL, Brandt CR. The effect of viral inoculum level and host age on disease incidence, disease severity, and mortality in a murine model of ocular HSV-1 infection. Curr Eye Res 1995;14:145-52.
39. Haeberle HA, Kuziel WA, Dieterich HJ, Casola A, Gatalica Z, Garofalo RP. Inducible expression of inflammatory chemokines in respiratory syncytial virus-infected mice: role of MIP-1α in lung pathology. J Virol 2001;75:878-90.
40. Liu MT, Armstrong D, Hamilton TA, Lane TE. Expression of Mig (monokine induced by interferon-γ) is important in T lymphocyte recruitment and host defense following viral infection of the central nervous system. J Immunol 2001;166:1790-5.
41. Weinberg JB, Lutzke ML, Efstathiou S, Kunkel SL, Rochford R. Elevated chemokine responses are maintained in lungs after clearance of viral infection. J Virol 2002;76:10518-23.
42. Sung RY, Hui SH, Wong CK, Lam CW, Yin J. A comparison of cytokine responses in respiratory syncytial virus and influenza A infections in infants. Eur J Pediatr 2001;160:117-22.
43. Salazar-Mather TP, Lewis CA, Biron CA. Type I interferons regulate inflammatory cell trafficking and macrophage inflammatory protein 1α delivery to the liver. J Clin Invest 2002;110:321-30.
44. Biron CA, Byron KS, Sullivan JL. Severe herpesvirus infections in an adolescent without natural killer cells. N Engl J Med 1989;320:1731-5.
45. Proudfoot AE, Buser R, Borlat F et al. Amino-terminally modified RANTES analogues demonstrate differential effects on RANTES receptors. J Biol Chem 1999;274:32478-85.
46. Elsner J, Petering H, Kimmig D, Wells TN, Proudfoot AE, Kapp A. The CC chemokine receptor antagonist Met-RANTES inhibits eosinophil effector functions. Int Arch Allergy Immunol 1999;118:462-5.
47. Matsui M, Weaver J, Proudfoot AE et al. Treatment of experimental autoimmune encephalomyelitis with the chemokine receptor antagonist Met-RANTES. J Neuroimmunol 2002;128:16-22.
48. Morteau O, Castagliuolo I, Mykoniatis A et al. Genetic deficiency in the chemokine receptor CCR1 protects against acute Clostridium difficile toxin A enteritis in mice. Gastroenterology 2002;122:725-33.
49. Plater-Zyberk C, Hoogewerf AJ, Proudfoot AE, Power CA, Wells TN. Effect of a CC chemokine receptor antagonist on collagen induced arthritis in DBA/1 mice. Immunol Lett 1997;57:117-20.
50. Stumbles PA, Strickland DH, Pimm CL et al. Regulation of dendritic cell recruitment into resting and inflamed airway epithelium: use of alternative chemokine receptors as a function of inducing stimulus. J Immunol 2001;167:228-34.
51. Tumpey TM, Fenton R, Molesworth-Kenyon S, Oakes JE, Lausch RN. Role for macrophage inflammatory protein 2 (MIP-2), MIP-1α, and interleukin-1α in the delayed-type hypersensitivity response to vital antigen. J Virol 2002;76:8050-7.
52. Ghiasi H, Cai S, Perng GC, Nesburn AB, Wechsler SL. The role of natural killer cells in protection of mice against death and corneal scarring following ocular HSV-1 infection. Antiviral Res 2000;45:33-45.
53. Milligan GN, Bourne N, Dudley KL. Role of polymorphonuclear leukocytes in resolution of HSV-2 infection of the mouse vagina. J Reprod Immunol 2001;49:49-65.
54. Huffnagle GB, McNeil LK, McDonald RA et al. Cutting edge: Role of C-C chemokine receptor 5 in organ-specific and innate immunity to Cryptococcus neoformans. J Immunol 1999;163:4642-6.
55. Domachowske JB, Bonville CA, Gao JL, Murphy PM, Easton AJ, Rosenberg HF. MIP-1α is produced but it does not control pulmonary inflammation in response to respiratory syncytial virus infection in mice. Cell Immunol 2000;206:1-6.
56. Nansen A, Christensen JP, Andreasen SO, Bartholdy C, Christensen JE, Thomsen AR. The role of CC chemokine receptor 5 in antiviral immunity. Blood 2002;99:1237-45.
57. Ellermann-Eriksen S. Autocrine secretion of interferon-α/β and tumour necrosis factor-α synergistically activates mouse macrophages after infection with herpes simplex virus type 2. J Gen Virol 1993;74:2191-9.
58. Zhou Y, Kurihara T, Ryseck RP et al. Impaired macrophage function and enhanced T cell-dependent immune response in mice lacking CCR5, the mouse homologue of the major HIV-1 coreceptor. J Immunol 1998;160:4018-25.
59. Makino Y, Cook DN, Smithies O et al. Impaired T cell function in RANTES-deficient mice. Clin Immunol 2002;102:302-9.
60. Bystry RS, Aluvihare V, Welch KA, Kallikourdis M, Betz AG. B cells and professional APCs recruit regulatory T cells via CCL4. Nat Immunol 2001;2:1126-32.